Literature DB >> 7964469

The role of transforming growth factor beta in the generation of suppression: an interaction between CD8+ T and NK cells.

J D Gray1, M Hirokawa, D A Horwitz.   

Abstract

CD8+ T cells have suppressor effector functions, but the mechanisms involved in the generation of this activity are poorly understood. We report that natural killer (NK) cells have an important role in the acquisition of this function. CD8+ cells induce NK cells to produce transforming growth factor-beta (TGF-beta) which, in turn, stimulates CD8+ T cells to become suppressors of antibody production. Using a monocyte-dependent and -independent method to induce antibody production, we first observed that the addition of NK cells to CD8+ cells was required for optimal suppression. Next, we determined that the interaction of CD8+ T cells with NK cells resulted in a striking increase NK cell TGF-beta mRNA and its production. This cytokine appeared to be involved in the induction of T suppressor cell activity since: (a) anti-TGF-beta 1 completely abrogated the suppression of immunoglobulin G synthesis; (b) TGF-beta 1 could substitute for NK cells in inducing CD8+ T cells to develop suppressor activity; and (c) a short exposure of T cells to TGF-beta 1 in the absence of B cells was sufficient for the generation of suppressor activity by CD8+ T cells. Interferon gamma did not have this property. These studies provide strong evidence that in addition to its suppressive properties, TGF-beta is involved in the generation of CD8+ T suppressor effector cells. Because NK cell function is decreased in many autoimmune diseases, these cells may fail to interact properly with these individuals' CD8+ cells in generating suppressors of aggressive anti-self responses.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7964469      PMCID: PMC2191718          DOI: 10.1084/jem.180.5.1937

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  29 in total

1.  Suppressive effect of human natural killer cells on Epstein-Barr virus-induced immunoglobulin synthesis.

Authors:  K Kuwano; S Arai; T Munakata; Y Tomita; Y Yoshitake; K Kumagai
Journal:  J Immunol       Date:  1986-09-01       Impact factor: 5.422

2.  Abnormal natural killer cell activity in systemic lupus erythematosus: an intrinsic defect in the lytic event.

Authors:  P Katz; A M Zaytoun; J H Lee; R S Panush; S Longley
Journal:  J Immunol       Date:  1982-11       Impact factor: 5.422

3.  Rapid Il-2-induced adherence of human natural killer cells. Expression of mRNA for cytokines and IL-2 receptors in adherent NK cells.

Authors:  D Vitolo; N L Vujanovic; H Rabinowich; M Schlesinger; R B Herberman; T L Whiteside
Journal:  J Immunol       Date:  1993-08-15       Impact factor: 5.422

4.  Depletion of NK cells with the lysosomotropic agent L-leucine methyl ester and the in vitro generation of NK activity from NK precursor cells.

Authors:  H Shau; S H Golub
Journal:  J Immunol       Date:  1985-02       Impact factor: 5.422

5.  Dysfunction of natural killer cells in multiple sclerosis: a possible pathogenetic factor.

Authors:  M Benczur; G G Petrányl; G Pálffy; M Varga; M Tálas; B Kotsy; I Földes; S R Hollán
Journal:  Clin Exp Immunol       Date:  1980-03       Impact factor: 4.330

6.  The isolation and characterization of the human suppressor inducer T cell subset.

Authors:  C Morimoto; N L Letvin; J A Distaso; W R Aldrich; S F Schlossman
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

7.  Human clones with natural killer function can activate B cells and secrete B cell differentiation factors.

Authors:  A Vyakarnam; M K Brenner; J E Reittie; C H Houlker; P J Lachmann
Journal:  Eur J Immunol       Date:  1985-06       Impact factor: 5.532

8.  Modulation of ongoing human immunoglobulin synthesis by natural killer cells.

Authors:  H Kimata; F Shanahan; M Brogan; S Targan; A Saxon
Journal:  Cell Immunol       Date:  1987-06       Impact factor: 4.868

9.  Suppressor cell function of human granular lymphocytes identified by the HNK-1 (Leu 7) monoclonal antibody.

Authors:  A B Tilden; T Abo; C M Balch
Journal:  J Immunol       Date:  1983-03       Impact factor: 5.422

10.  Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes.

Authors:  J H Kehrl; A B Roberts; L M Wakefield; S Jakowlew; M B Sporn; A S Fauci
Journal:  J Immunol       Date:  1986-12-15       Impact factor: 5.422

View more
  27 in total

Review 1.  Reversal of tumor-induced immunosuppression by TGF-beta inhibitors.

Authors:  Slawomir Wojtowicz-Praga
Journal:  Invest New Drugs       Date:  2003-02       Impact factor: 3.850

2.  Suppression of Murine Lupus by CD4+ and CD8+ Treg Cells Induced by T Cell-Targeted Nanoparticles Loaded With Interleukin-2 and Transforming Growth Factor β.

Authors:  David A Horwitz; Sean Bickerton; Michael Koss; Tarek M Fahmy; Antonio La Cava
Journal:  Arthritis Rheumatol       Date:  2019-03-05       Impact factor: 10.995

3.  Inhibition of interleukin-2 by a Gram-positive bacterium, Streptococcus mutans.

Authors:  L M Plitnick; J A Banas; D M Jelley-Gibbs; J O'neil; T Christian; S P Mudzinski; E J Gosselin
Journal:  Immunology       Date:  1998-12       Impact factor: 7.397

4.  Phenotyping of peripheral blood lymphocytes in adult coeliac disease.

Authors:  A Di Sabatino; E Bertrandi; M Casadei Maldini; F Pennese; F Proietti; G R Corazza
Journal:  Immunology       Date:  1998-12       Impact factor: 7.397

5.  The emergence of non-cytolytic NK1.1+ T cells in the long-term culture of murine tumour-infiltrating lymphocytes: a possible role of transforming growth factor-beta.

Authors:  K Tamada; M Harada; O Ito; M Takenoyama; T Mori; G Matsuzaki; K Nomoto
Journal:  Immunology       Date:  1996-12       Impact factor: 7.397

6.  The immunosuppressive role of adenosine A2A receptors in ischemia reperfusion injury and islet transplantation.

Authors:  Preeti Chhabra; Joel Linden; Peter Lobo; Mark Douglas Okusa; Kenneth Lewis Brayman
Journal:  Curr Diabetes Rev       Date:  2012-11

Review 7.  Granulocyte-macrophage colony-stimulating factor and the immune system.

Authors:  P E Tarr
Journal:  Med Oncol       Date:  1996-09       Impact factor: 3.064

8.  Therapeutic polyclonal human CD8+ CD25+ Fox3+ TNFR2+ PD-L1+ regulatory cells induced ex-vivo.

Authors:  David A Horwitz; Stephanie Pan; Jing-Ni Ou; Julie Wang; Maogen Chen; J Dixon Gray; Song Guo Zheng
Journal:  Clin Immunol       Date:  2013-08-20       Impact factor: 3.969

Review 9.  Induction of immune tolerance by activation of CD8+ T suppressor/regulatory cells in lupus-prone mice.

Authors:  Brian J Skaggs; Ram Pyare Singh; Bevra H Hahn
Journal:  Hum Immunol       Date:  2008-09-24       Impact factor: 2.850

10.  Failure of gamma interferon but not interleukin-10 expression in response to human papillomavirus type 11 E6 protein in respiratory papillomatosis.

Authors:  James A DeVoti; Bettie M Steinberg; David W Rosenthal; Lynda Hatam; Andrea Vambutas; Allan L Abramson; Mark J Shikowitz; Vincent R Bonagura
Journal:  Clin Diagn Lab Immunol       Date:  2004-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.